AGIO vs MGM · rev $65.5M vs P/E 64, rev $4.45B
Agios Pharm (AGIO) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
AGIO currently screens at market cap $1.68B. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the AGIO and MGM stock pages for the full models.
Not investment advice.